Insurer's price calculator severely underestimates breast MRI cost for Philadelphia woman

Although a new federal law which took effect Jan. 1 requires hospitals to post prices of all services offered online, including imaging examinations, and has encouraged many insurance providers to invest in price calculators for patients to determine out-of-pocket costs, one Philadelphia woman discovered that they may severely underestimate actual prices, according to a recent report by The Philadelphia Inquirer.   

Knowing her breast MRI wouldn’t be covered in-full by insurance, Michelle Smith used an online cost calculator from her insurance provider, UnitedHealthcare, to estimate out-of-pocket costs for the exam. The online tool—which suggested the facility Smith used to get the breast MRI—told her the cost of the procedure in her area ranged from $783 to $1,375. But Smith was shocked to discover she was billed $3,237 for the exam.

She learned she was billed double what the price calculator estimated because she had her exam at an imaging center that was inside of a hospital, as opposed to in a separate building affiliated with the hospital.  

The entire bill, therefore, expressed costs for the exam as well as fees for the administrative and operating costs associated with running a hospital. This was unknown to Smith and was not initially listed on the price calculator.   

“I do not have a problem paying the bill. It’s not a financial thing for me. It’s a principle thing. I feel like I am an informed person and can’t accurately use the cost estimator—there must be plenty of people who can’t,” Smith told the Inquirer. 

Read the entire article below.  

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.